BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 37144561)

  • 1. A common variant in MTHFR influences response to chemoradiotherapy and recurrence of rectal cancer.
    Nikas JB; Lee JT; Maring ED; Washechek-Aletto J; Felmlee-Devine D; Johnson RA; Smyrk TC; Tawadros PS; Boardman LA; Steer CJ
    Am J Cancer Res; 2015; 5(10):3231-40. PubMed ID: 26693073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The therapeutic potential of targeting regulated non-apoptotic cell death.
    Hadian K; Stockwell BR
    Nat Rev Drug Discov; 2023 Sep; 22(9):723-742. PubMed ID: 37550363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of tumor resistance to radiotherapy.
    Wu Y; Song Y; Wang R; Wang T
    Mol Cancer; 2023 Jun; 22(1):96. PubMed ID: 37322433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron metabolism in colorectal cancer: a balancing act.
    Estêvão D; da Cruz-Ribeiro M; Cardoso AP; Costa ÂM; Oliveira MJ; Duarte TL; da Cruz TB
    Cell Oncol (Dordr); 2023 Dec; 46(6):1545-1558. PubMed ID: 37273145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Induction Mechanism of Ferroptosis, Necroptosis, and Pyroptosis in Inflammatory Bowel Disease, Colorectal Cancer, and Intestinal Injury.
    Zhou P; Zhang S; Wang M; Zhou J
    Biomolecules; 2023 May; 13(5):. PubMed ID: 37238692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ferroptosis-Mediated Cell Death Induced by NCX4040, The Non-Steroidal Nitric Oxide Donor, in Human Colorectal Cancer Cells: Implications in Therapy.
    Sinha BK; Bortner CD; Jarmusch AK; Tokar EJ; Murphy C; Wu X; Winter H; Cannon RE
    Cells; 2023 Jun; 12(12):. PubMed ID: 37371096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel defined pyroptosis-related gene signature predicts prognosis and correlates with the tumour immune microenvironment in lung adenocarcinoma.
    Chen Z; Ge L; Xu S; Li Q; Zhou L
    Sci Rep; 2023 Jun; 13(1):9921. PubMed ID: 37337018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Released dsDNA-triggered inflammasomes serve as intestinal radioprotective targets.
    Chen L; Wang Z; Wu J; Yao Q; Peng J; Zhang C; Chen H; Li Y; Jiang Z; Liu Y; Shi C
    Clin Transl Immunology; 2023; 12(6):e1452. PubMed ID: 37333051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between polymorphisms in leptin and leptin receptor genes and colorectal cancer survival.
    Du M; Wang Y; Vallis J; Shariati M; Parfrey PS; Mclaughlin JR; Wang PP; Zhu Y
    Cancer Biol Med; 2023 Jun; 20(6):438-51. PubMed ID: 37282602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of a novel pyrotosis-related prognostic model of esophageal square cell carcinoma and determination of the anti-tumor effect of WFDC12.
    Zhuang Y; Wang L; Ji C; Sun Y; Shao F
    Funct Integr Genomics; 2023 May; 23(2):177. PubMed ID: 37225895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erianin inhibits the growth and metastasis through autophagy-dependent ferroptosis in KRAS
    Miao Q; Deng WQ; Lyu WY; Sun ZT; Fan SR; Qi M; Qiu SH; Zhu YR; Lin JP; Chen MF; Deng LJ
    Free Radic Biol Med; 2023 Aug; 204():301-312. PubMed ID: 37217090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated analysis of diagnostic, prognostic value and potential drug treatment of GSDME in head and neck squamous cell carcinoma.
    Hu R; Lu M; She L
    Eur Arch Otorhinolaryngol; 2023 Sep; 280(9):4239-4253. PubMed ID: 37204444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and in vitro and in vivo validation of the key role of GSDME in pyroptosis-related genes signature in hepatocellular carcinoma.
    Chen X; Yang M; Wang L; Wang Y; Tu J; Zhou X; Yuan X
    BMC Cancer; 2023 May; 23(1):411. PubMed ID: 37149620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanism of ferroptosis and its related diseases.
    Feng S; Tang D; Wang Y; Li X; Bao H; Tang C; Dong X; Li X; Yang Q; Yan Y; Yin Z; Shang T; Zheng K; Huang X; Wei Z; Wang K; Qi S
    Mol Biomed; 2023 Oct; 4(1):33. PubMed ID: 37840106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphisms in genes regulating cell death and prognosis of patients with rectal cancer receiving postoperative chemoradiotherapy.
    Chen H; Yin L; Yang J; Ren N; Chen J; Lu Q; Huang Y; Feng Y; Wang W; Wang S; Liu Y; Song Y; Li Y; Jin J; Tan W; Lin D
    Cancer Biol Med; 2023 May; 20(4):297-316. PubMed ID: 37144561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Associations of genetic variations in pyroptosis related genes with acute adverse events in postoperative rectal cancer patients receiving concurrent chemoradiotherapy].
    Chen HX; Ren NX; Yang J; Chen JN; Lu QX; Feng YR; Huang Y; Yin LL; Lin DX; Li YX; Jin J; Tan W
    Zhonghua Zhong Liu Za Zhi; 2023 Feb; 45(2):146-152. PubMed ID: 36781235
    [No Abstract]   [Full Text] [Related]  

  • 17. Associations of Genetic Variations in Mismatch Repair Genes MSH3 and PMS1 with Acute Adverse Events and Survival in Patients with Rectal Cancer Receiving Postoperative Chemoradiotherapy.
    Yang J; Huang Y; Feng Y; Li H; Feng T; Chen J; Yin L; Wang W; Wang S; Liu Y; Song Y; Li Y; Jin J; Tan W; Lin D
    Cancer Res Treat; 2019 Jul; 51(3):1198-1206. PubMed ID: 30590005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genetic variations in MLH3 and MSH2 genes are associated with the sensitivity and prognosis in locally advanced rectal cancer patients receiving preoperative chemoradiotherapy].
    Yang J; Wang X; Zou SM; Li HM; Xiao Q; Feng YR; Huang Y; Feng T; Chen JN; Lin DX; Li YX; Jin J; Tan W
    Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):433-440. PubMed ID: 29936769
    [No Abstract]   [Full Text] [Related]  

  • 19. Emerging Roles of 5-Lipoxygenase Phosphorylation in Inflammation and Cell Death.
    Sun QY; Zhou HH; Mao XY
    Oxid Med Cell Longev; 2019; 2019():2749173. PubMed ID: 31871543
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.